Dapagliflozin Quickly Reduces Heart Failure Events Dapagliflozin Quickly Reduces Heart Failure Events

A significant reduction of the incidence of cardiovascular death or worsening heart failure with dapagliflozin became apparent in DAPA-HF within 28 days after patients started treatment.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news